Today's 5 Stock Ideas:
Target (TGT) - Shares were down 25% following mixed Q1 results. Target management noted the company's 5.3% operating margin "was well below expectations." The stock was the
SIRIUSPOINT ANNOUNCES DANIEL S. LOEB JOINING BOARD OF DIRECTORS
Loeb to Focus on Executing Asset Management Strategy and Recruiting Permanent CEO
HAMILTON, Bermuda, May 17, 2022 /PRNewswire/ -- SiriusPoint
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.